These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 31191529

  • 1. The CD14+HLA-DRlo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy.
    Mengos AE, Gastineau DA, Gustafson MP.
    Front Immunol; 2019; 10():1147. PubMed ID: 31191529
    [Abstract] [Full Text] [Related]

  • 2. Elevated frequencies of CD14+HLA-DRlo/neg MDSCs in COVID-19 patients.
    Xue G, Jiang M, Zhao R, Le A, Li J.
    Aging (Albany NY); 2021 Feb 26; 13(5):6236-6246. PubMed ID: 33640878
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
    Mougiakakos D, Jitschin R, von Bahr L, Poschke I, Gary R, Sundberg B, Gerbitz A, Ljungman P, Le Blanc K.
    Leukemia; 2013 Feb 26; 27(2):377-88. PubMed ID: 22828446
    [Abstract] [Full Text] [Related]

  • 5. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.
    Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, Dietz AB.
    Neuro Oncol; 2010 Jul 26; 12(7):631-44. PubMed ID: 20179016
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive CD14+HLA-DRlo/neg monocytes are elevated in pancreatic cancer and "primed" by tumor-derived exosomes.
    Javeed N, Gustafson MP, Dutta SK, Lin Y, Bamlet WR, Oberg AL, Petersen GM, Chari ST, Dietz AB, Mukhopadhyay D.
    Oncoimmunology; 2017 Jul 26; 6(1):e1252013. PubMed ID: 28197368
    [Abstract] [Full Text] [Related]

  • 7. Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses.
    Laborde RR, Lin Y, Gustafson MP, Bulur PA, Dietz AB.
    Front Immunol; 2014 Jul 26; 5():147. PubMed ID: 24772111
    [Abstract] [Full Text] [Related]

  • 8. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
    Höchst B, Schildberg FA, Sauerborn P, Gäbel YA, Gevensleben H, Goltz D, Heukamp LC, Türler A, Ballmaier M, Gieseke F, Müller I, Kalff J, Kurts C, Knolle PA, Diehl L.
    J Hepatol; 2013 Sep 26; 59(3):528-35. PubMed ID: 23665041
    [Abstract] [Full Text] [Related]

  • 9. Circulating CD14+ HLA-DRlo/- monocytic cells as a biomarker for epithelial ovarian cancer progression.
    Stenzel AE, Abrams SI, Joseph JM, Goode EL, Tario JD, Wallace PK, Kaur D, Adamson AK, Buas MF, Lugade AA, Laslavic A, Taylor SE, Orr B, Edwards RP, Elishaev E, Odunsi K, Mongiovi JM, Etter JL, Winham SJ, Kaufmann SH, Modugno F, Moysich KB.
    Am J Reprod Immunol; 2021 Mar 26; 85(3):e13343. PubMed ID: 32905653
    [Abstract] [Full Text] [Related]

  • 10. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G, Wu K, Tao K, Lu X, Ma J, Mao Z, Li H, Shi L, Li J, Niu Y, Xiang F, Wang G.
    Mol Med Rep; 2015 Jul 26; 12(1):760-8. PubMed ID: 25695487
    [Abstract] [Full Text] [Related]

  • 11. Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma.
    Gustafson MP, Lin Y, Bleeker JS, Warad D, Tollefson MK, Crispen PL, Bulur PA, Harrington SM, Laborde RR, Gastineau DA, Leibovich BC, Cheville JC, Kwon ED, Dietz AB.
    Clin Cancer Res; 2015 Sep 15; 21(18):4224-33. PubMed ID: 25999436
    [Abstract] [Full Text] [Related]

  • 12. Immune independent crosstalk between lymphoma and myeloid suppressor CD14+HLA-DRlow/neg monocytes mediates chemotherapy resistance.
    Zhang ZJ, Bulur PA, Dogan A, Gastineau DA, Dietz AB, Lin Y.
    Oncoimmunology; 2015 Apr 15; 4(4):e996470. PubMed ID: 26137410
    [Abstract] [Full Text] [Related]

  • 13. Immunoparalysis: Clinical and immunological associations in SIRS and severe sepsis patients.
    Papadopoulos P, Pistiki A, Theodorakopoulou M, Christodoulopoulou T, Damoraki G, Goukos D, Briassouli E, Dimopoulou I, Armaganidis A, Nanas S, Briassoulis G, Tsiodras S.
    Cytokine; 2017 Apr 15; 92():83-92. PubMed ID: 28119177
    [Abstract] [Full Text] [Related]

  • 14. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.
    Vuk-Pavlović S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, Dietz AB.
    Prostate; 2010 Mar 01; 70(4):443-55. PubMed ID: 19902470
    [Abstract] [Full Text] [Related]

  • 15. Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.
    Huang A, Zhang B, Wang B, Zhang F, Fan KX, Guo YJ.
    Cancer Immunol Immunother; 2013 Sep 01; 62(9):1439-51. PubMed ID: 23760662
    [Abstract] [Full Text] [Related]

  • 16. Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.
    Spinetti T, Hirzel C, Fux M, Walti LN, Schober P, Stueber F, Luedi MM, Schefold JC.
    Anesth Analg; 2020 Oct 01; 131(4):993-999. PubMed ID: 32925314
    [Abstract] [Full Text] [Related]

  • 17. Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: profile comparison.
    Brusa D, Simone M, Gontero P, Spadi R, Racca P, Micari J, Degiuli M, Carletto S, Tizzani A, Matera L.
    Int J Urol; 2013 Oct 01; 20(10):971-8. PubMed ID: 23421558
    [Abstract] [Full Text] [Related]

  • 18. CD14+ CD15- HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure.
    Bernsmeier C, Triantafyllou E, Brenig R, Lebosse FJ, Singanayagam A, Patel VC, Pop OT, Khamri W, Nathwani R, Tidswell R, Weston CJ, Adams DH, Thursz MR, Wendon JA, Antoniades CG.
    Gut; 2018 Jun 01; 67(6):1155-1167. PubMed ID: 28592438
    [Abstract] [Full Text] [Related]

  • 19. Monocyte subset distribution and surface expression of HLA-DR and CD14 in patients after cardiopulmonary resuscitation.
    Asmussen A, Busch HJ, Helbing T, Bemtgen X, Smolka C, Bode C, Fink K, Grundmann S.
    Sci Rep; 2021 Jun 11; 11(1):12403. PubMed ID: 34117334
    [Abstract] [Full Text] [Related]

  • 20. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
    Wang HY, Zhao R, Ren H, Zou MJ, Zhang J, Zhang Y.
    Zhonghua Yi Xue Za Zhi; 2017 Sep 12; 97(34):2663-2669. PubMed ID: 28910953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.